Salvage stereotactic reirradiation using the CyberKnife for the local recurrence of nasal or paranasal carcinoma

Radiotherapy and Oncology

Volumn 104, Issue 3, 2012, Pages 355-360

  Iwata, Hiromitsu ^a,b   Tatewaki, Koshi ^b   Inoue, Mitsuhiro ^c   Yokota, Naoki ^b,d   Sato, Kengo ^b,e   Shibamoto, Yuta ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Department of Neurosurgery ^*  (Japan)

^c Yokohama CyberKnife Center   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

CyberKnife; Recurrent nasal and paranasal carcinoma; Reirradiation; Stereotactic radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BONE NECROSIS; BRAIN EDEMA; BRAIN NECROSIS; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CYBERKNIFE; DERMATITIS; DEVICE SAFETY; EPISTAXIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NOSE CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARANASAL SINUS CARCINOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; SALVAGE THERAPY; STEREOTACTIC RADIOSURGERY; TISSUE NECROSIS; TRISMUS; TUMOR VOLUME; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; RADIOSURGERY; SALVAGE THERAPY;

EID: 84867088373     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.01.017     Document Type: Article

References (32)

1. C.S. Muir, and J. Nectoux Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses Clin Otolaryngol Allied Sci 5 1980 195 211
2. H. Nishino, M. Miyata, M. Morita, K. Ishikawa, T. Kanazawa, and K. Ichimura Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma Cancer 89 2000 1925 1932
3. R. Tiwari, J.A. Hardillo, and D. Mehta Squamous cell carcinoma of maxillary sinus Head Neck 22 2000 164 169
4. D.I. Rosenthal, J.L. Barker Jr., and A.K. El-Naggar Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype Cancer 101 2004 2567 2573
5. J.S. Lewis, and E.B. Castro Cancer of the nasal cavity and paranasal sinuses J Laryngol Otol 86 1972 255 262
6. M.K. Gibson, Y. Li, and B. Murphy Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group J Clin Oncol 23 2005 3562 3567
7. F. Hoebers, W. Heemsbergen, and S. Moor Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity Int J Radiat Oncol Biol Phys 81 2011 e111 e118
8. J.A. Langendijk, N. Kasperts, C.R. Leemans, P. Doornaert, and B.J. Slotman A phase II study of primary reirradiation in squamous cell carcinoma of head and neck Radiother Oncol 78 2006 306 312
9. S.A. Spencer, J. Harris, and R.H. Wheeler Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck Head Neck 30 2008 281 288
10. C.J. Langer, J. Harris, and E.M. Horwitz Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911 J Clin Oncol 25 2007 4800 4805
11. S.K. Nath, A.P. Sandhu, and D. Kim Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer Radiother Oncol 99 2011 12 17
12. H. Iwata, Y. Shibamoto, and C. Hashizume Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity Technol Cancer Res Treat 9 2010 619 627
13. H. Iwata, K. Sato, and K. Tatewaki Hypofractionated stereotactic radiotherapy with CyberKnife for non-functioning pituitary adenoma: high local control with low toxicity Neuro-oncol 13 2011 916 922
14. H. Inoue, R. Omori, and K. Sato The accuracy of the CyberKnife J Jpn Soc Ther Radiol Oncol 15 2003 177 185
15. N. Kasperts, B.J. Slotman, C.R. Leemans, R. de Bree, P. Doornaert, and J.A. Langendijk Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma Cancer 106 2006 1536 1547
16. Y.S. Nagar, S. Singh, and N.R. Datta Chemo-reirradiation in persistent/recurrent head and neck cancers Jpn J Clin Oncol 34 2004 61 68
17. E.P. Sulman, D.L. Schwartz, and T.T. Le IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes Int J Radiat Oncol Biol Phys 73 2009 399 409
18. M. Cengiz, G. Özyigit, and G. Yazici Salvage reirradiation with stereotactic body radiotherapy for locally recurrent head-and-neck tumors Int J Radiat Oncol Biol Phys 81 2011 104 109
19. G. Ozyigit, M. Cengiz, and G. Yazici A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 81 2011 e263 e268
20. D.E. Heron, R.L. Ferris, and M. Karamouzis Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial Int J Radiat Oncol Biol Phys 75 2009 1493 1500
21. E. Shaw, R. Kline, and M. Gillin Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines Int J Radiat Oncol Biol Phys 27 1993 1231 1239
22. S.R. Mabanta, W.M. Mendenhall, S.P. Stringer, and N.J. Cassisi Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes Head Neck 21 1999 591 594
23. J.K. Salama, E.E. Vokes, and S.J. Chmura Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 64 2006 382 391
24. Y. Shibamoto, Y. Yukawa, and K. Tsutsui Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites Jpn J Cancer Res 77 1986 908 915
25. L. Walsh, J.L. Stanfield, and L.C. Cho Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model Eur Urol 50 2006 795 800
26. W.T. Sause, J.S. Cooper, and S. Rush Fraction size in external beam radiation therapy in the treatment of melanoma Int J Radiat Oncol Biol Phys 20 1991 429 432
27. C.R. King, J. Lehmann, J.R. Adler, and J. Hai CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility Technol Cancer Res Treat 2 2003 25 30
28. H. Iwata, Y. Shibamoto, and R. Murata Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study Int J Radiat Oncol Biol Phys 75 2009 482 488
29. Y. Shibamoto, S. Otsuka, and H. Iwata Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model J Radiat Res 53 2012 1 9
30. K.E. Rusthoven, S.J. Feigenberg, and D. Raben Initial results of a phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer Int J Radiat Oncol Biol Phys 78 2010 1020 1025
31. S.E. Combs, A. Kalbe, and A. Nikoghosyan Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region Radiother Oncol 98 2011 63 67
32. C.B. Simone 2nd, D. Ly, and T.D. Dan Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer Radiother Oncol 2011 376 382